Company intelligence / Profile preview

OraVital

Toronto, Ontario, Canadaoravital.com ↗

Ownership: Private
Development stage: Commercial

Overview

OraVital has commercialized a proprietary five-step system for diagnosing and treating oral infections. The system uses whole-mouth microbiology testing to identify pathogenic biofilms and provides targeted antibiotic rinses and maintenance protocols. Clinical use in Canada and the US has shown improved outcomes for patients with periodontal disease, halitosis, peri‑implantitis, and dental decay by addressing the root microbial causes rather than just symptoms.

Therapeutic areas: OtherGastroenterologyInfectious Diseases
Modalities: DeviceDiagnostic testSmall molecule (antibiotic rinses)Probiotic therapy (maintenance)
Industry: Molecular Diagnostics

Drug pipeline

3 assets

OraVital Probiotic Rinse

Unknown

2 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on OraVital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on OraVital.

Explore the full profile